Literature DB >> 28425000

Medical Care, Screening and Regularization of Sub-Saharan Irregular Migrants Affected by Hepatitis B in France and Italy.

Cecilia Santilli1,2,3,4.   

Abstract

Both in France and in Italy hepatitis B is present mostly among the migrant population coming from sub-Saharan Africa and mainly among those migrants having a poor socio-economic background. This article is aimed at assaying the impact of public policies adopted by France and Italy for migrants' health on the treatment of migrants with HBV. The article is based on semi-structured interviews conducted with 30 immigrant adults taken into care by two associations dealing with medical, psychological and social issues of immigrants applying for a residence permit, mainly asylum seekers. The results of this study bring to light specific difficulties relating to national contexts, to the type of HBV (inactive or active) and to the administrative situation of the migrants. In France irregular migrants are screened in humanitarian associations. In Italy the screening is done in public hospitals. In both countries, only migrants suffering from chronic hepatitis B obtain a residence permit for medical reasons. More migrants in Italy than in France abandon HBV treatment. This study describes how specific national immigration and health policies impact in a different way the therapeutic and social path of migrants suffering from hepatitis B. The analysis provides useful material for the development of strategies to prevent and control hepatitis B among the migrant population. It also shows how social determinants affect migrants' health more than values or cultural factors do.

Entities:  

Keywords:  France; Hepatitis B prevention; Immigrant and health policies; Irregular migrants; Italy; Medical care; Migrant health

Mesh:

Year:  2018        PMID: 28425000     DOI: 10.1007/s10903-017-0585-5

Source DB:  PubMed          Journal:  J Immigr Minor Health        ISSN: 1557-1912


  5 in total

Review 1.  Epidemiology of hepatitis B in Europe and worldwide.

Authors:  Miriam J Alter
Journal:  J Hepatol       Date:  2003       Impact factor: 25.083

Review 2.  Achieving universal health coverage in France: policy reforms and the challenge of inequalities.

Authors:  Olivier Nay; Sophie Béjean; Daniel Benamouzig; Henri Bergeron; Patrick Castel; Bruno Ventelou
Journal:  Lancet       Date:  2016-05-01       Impact factor: 79.321

3.  [Chronic hepatitis B and HIV care: the key role of the doctor-patient relationship].

Authors:  Dolorès Pourette
Journal:  Sante Publique       Date:  2013 Sep-Oct       Impact factor: 0.203

4.  [Representations and disease experience of hepatitis B by Sub-Saharan patients in Ivory Coast and France].

Authors:  Dolorès Pourette; Catherine Enel
Journal:  Sante Publique       Date:  2014 Nov-Dec       Impact factor: 0.203

5.  [Health professionals' perceptions and screening for hepatitis B and C among migrants: a qualitative study in Côte-d'Or, France].

Authors:  Catherine Enel; Anne Minello; Patrick Hillon
Journal:  Sante Publique       Date:  2012 Jul-Aug       Impact factor: 0.203

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.